DK1095939T3 - Fremgangsmåde til fremstilling af cykliske piperidinylaminomethyltrifluormethyletherforbindelser - Google Patents

Fremgangsmåde til fremstilling af cykliske piperidinylaminomethyltrifluormethyletherforbindelser

Info

Publication number
DK1095939T3
DK1095939T3 DK00308640T DK00308640T DK1095939T3 DK 1095939 T3 DK1095939 T3 DK 1095939T3 DK 00308640 T DK00308640 T DK 00308640T DK 00308640 T DK00308640 T DK 00308640T DK 1095939 T3 DK1095939 T3 DK 1095939T3
Authority
DK
Denmark
Prior art keywords
piperidinylaminomethyltrifluoromethyl
cyclic
preparation
ether compounds
ether
Prior art date
Application number
DK00308640T
Other languages
Danish (da)
English (en)
Inventor
Stephane Caron
Enrique Vazquez
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Application granted granted Critical
Publication of DK1095939T3 publication Critical patent/DK1095939T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/96Esters of carbonic or haloformic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/76Benzo[c]pyrans

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
DK00308640T 1999-10-18 2000-10-02 Fremgangsmåde til fremstilling af cykliske piperidinylaminomethyltrifluormethyletherforbindelser DK1095939T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16022699P 1999-10-18 1999-10-18

Publications (1)

Publication Number Publication Date
DK1095939T3 true DK1095939T3 (da) 2004-04-13

Family

ID=22576040

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00308640T DK1095939T3 (da) 1999-10-18 2000-10-02 Fremgangsmåde til fremstilling af cykliske piperidinylaminomethyltrifluormethyletherforbindelser

Country Status (24)

Country Link
US (2) US6486325B1 (sh)
EP (1) EP1095939B1 (sh)
JP (1) JP3564685B2 (sh)
KR (1) KR100459952B1 (sh)
CN (1) CN1293193A (sh)
AR (1) AR026053A1 (sh)
AT (1) ATE257477T1 (sh)
AU (1) AU784275B2 (sh)
BR (1) BR0004901A (sh)
CA (1) CA2323315C (sh)
CZ (1) CZ299029B6 (sh)
DE (1) DE60007599T2 (sh)
DK (1) DK1095939T3 (sh)
ES (1) ES2211455T3 (sh)
HU (1) HUP0004061A2 (sh)
ID (1) ID27627A (sh)
IL (1) IL139012A (sh)
IN (1) IN190078B (sh)
PL (1) PL343290A1 (sh)
PT (1) PT1095939E (sh)
RU (1) RU2184116C1 (sh)
TR (1) TR200003002A2 (sh)
YU (1) YU60600A (sh)
ZA (1) ZA200005695B (sh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW426667B (en) * 1997-11-19 2001-03-21 Pfizer Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance P antagonists
WO2003053929A1 (fr) * 2001-12-21 2003-07-03 Toray Fine Chemicals Co., Ltd. Procede de production de derives de cis-piperidine optiquement actifs

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0581777A1 (en) * 1991-03-26 1994-02-09 Pfizer Inc. Stereoselective preparation of substituted piperidines
US5294744A (en) * 1993-04-20 1994-03-15 Pfizer Inc. Formylation process for aromatic aldehydes
ES2155601T3 (es) * 1995-07-07 2001-05-16 Pfizer Compuestos de benzolactama sustituidos como antagonistas de la sustancia p.
TW426667B (en) * 1997-11-19 2001-03-21 Pfizer Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance P antagonists
CA2374643C (en) * 1999-05-21 2006-02-14 Pfizer Products Inc. 1-trifluoromethyl-4-hydroxy-7-piperidinylaminomethylchroman derivatives as substance p antagonists

Also Published As

Publication number Publication date
PL343290A1 (en) 2001-04-23
CZ20003840A3 (cs) 2002-02-13
JP3564685B2 (ja) 2004-09-15
ES2211455T3 (es) 2004-07-16
ZA200005695B (en) 2002-04-16
PT1095939E (pt) 2004-04-30
BR0004901A (pt) 2001-05-29
HU0004061D0 (en) 2000-12-28
IL139012A0 (en) 2001-11-25
KR100459952B1 (ko) 2004-12-04
IL139012A (en) 2007-06-17
US20030236268A1 (en) 2003-12-25
HUP0004061A2 (hu) 2002-05-29
DE60007599D1 (de) 2004-02-12
EP1095939B1 (en) 2004-01-07
CN1293193A (zh) 2001-05-02
AR026053A1 (es) 2002-12-26
ID27627A (id) 2001-04-19
IN190078B (sh) 2003-06-07
EP1095939A2 (en) 2001-05-02
CA2323315C (en) 2008-07-29
US6486325B1 (en) 2002-11-26
CA2323315A1 (en) 2001-04-18
EP1095939A3 (en) 2001-05-23
CZ299029B6 (cs) 2008-04-09
AU6547400A (en) 2001-04-26
ATE257477T1 (de) 2004-01-15
KR20010051069A (ko) 2001-06-25
RU2184116C1 (ru) 2002-06-27
AU784275B2 (en) 2006-03-02
DE60007599T2 (de) 2004-11-11
YU60600A (sh) 2002-12-10
JP2001151773A (ja) 2001-06-05
TR200003002A2 (tr) 2001-05-21

Similar Documents

Publication Publication Date Title
DK1173431T3 (da) Fremgangsmåde til fremstilling af citalopram
DK1105382T3 (da) Fremgangsmåde til fremstilling af citalopram
DK1159274T3 (da) Fremgangsmåde til fremstilling af citalopram
DK1296935T3 (da) Fremgangsmåde til fremstilling af substituerede octanoylamider
DK1277722T3 (da) Fremgangsmåde til fremstilling af methanol
DK1123284T3 (da) Fremgangsmåde til fremstilling af citalopram
DK1008577T4 (da) Fremgangsmåde til fremstilling af methanol
DK1296656T3 (da) Fremgangsmåde til fremstilling af et præparat
DK1326585T3 (da) Fremgangsmåde til fremstilling af pulverformuleringer
DK1181272T3 (da) Fremgangsmåde til fremstilling af rent citalopram
DK1181713T3 (da) Fremgangsmåde til fremstilling af rent citalopram
DK1150966T3 (da) Fremgangsmåde til fremstilling af 5-cyanophthalid
DK1309582T3 (da) Fremgangsmåde til fremstilling af citalopram
DK1165576T3 (da) Fremgangsmåde til fremstilling af amin-platin-komplekser
DK1309545T3 (da) Fremgangsmåde til fremstilling af alkylarylsulfonater
DK1140886T3 (da) Fremgangsmåde til fremstilling af 5-cyanophtalid
DK1396483T3 (da) Fremgangsmåde til fremstilling af dimethylether
DK1407037T3 (da) Fremgangsmåde til fremstilling af tagatose
DK1345939T3 (da) Fremgangsmåde til fremstilling af sulfonamidsubstituerede imidazotriazinoner
DK1187833T3 (da) Fremgangsmåde til fremstilling af thiamethoxam
DK1326836T3 (da) Fremgangsmåde til fremstilling af 3-amino-2-chlor-4-methylpyridin
DK1296970T3 (da) Fremgangsmåde til fremstilling af citalopram
DK1298124T3 (da) Fremgangsmåde til fremstilling af citalopram
DK0985733T3 (da) Fremgangsmåde til fremstilling af cyclodextrin
DK1203000T3 (da) Fremgangsmåde til fremstilling af phosphonomethylglycin